Exploring the Lung-Liver Axis in Pulmonary Arterial Hypertension

By afschroeder • May 16, 2026

Singh N, Lawson J, Ragavendran A, Banerjee S, Hon A, Vega A, Hong J, Mullin CJ, Pereira M, Sherman-Roe A, Jorrin AT, Cayton T, Fishbein G, Klinger JR, Oldham WM, Wang RS, Dai Z, Fallon M, Harrington EO, Liang OD, Umar S, Ventetuolo CE. Exploring the Lung-Liver Axis in Pulmonary Arterial Hypertension. Compr Physiol. 2026 Jun;16(3):e70171. doi: 10.1002/cph4.70171. PMID: 42138622; PMCID: PMC13178415.

Tags: endothelial cell, hepatic fibrosis, hepatic growth factor, model for end stage liver disease, Publications, pulmonary arterial hypertension, pulmonary vascular inflammation, Pulmonary, Critical Care & Sleep Medicine, Sugen‐hypoxia

cfDNA derived gene signatures as surrogate for microvascular invasion in HCC

Gong R, Wang L, Xue D, Cai J, Jiang Y, Huang J, Zhu J, Li Z, Ke A, Shi G, Wang J, Wang W, Zheng[...]

Hidradenitis in Pediatrics

Dhillon S, Horneck N, Smogorzewski J. Hidradenitis in Pediatrics. Adv Pediatr. 2026 Aug;73(1):295-307. doi: 10.1016/j.yapd.2025.12.007. Epub 2026 May 21. PMID: 42481098.

Impact of antenatal screening for Chlamydia and Gonorrhea on pregnancy outcomes in South African women

Nyemba DC, de Voux A, Mvududu R, Peters RPH, Delany-Moretlwe S, Johnson LF, Coates TJ, Myer L, Davey DLJ. Impact of antenatal screening for Chlamydia[...]